Hologic (NASDAQ:HOLX) Downgraded to “Hold” Rating by StockNews.com
StockNews.com lowered shares of Hologic (NASDAQ:HOLX – Free Report) from a buy rating to a hold rating in a research report sent to investors on Monday morning. Several other research analysts also recently weighed in on the stock. Raymond James restated an “outperform” rating and set a $71.00 price target (down previously from $90.00) on […]
StockNews.com lowered shares of Hologic (NASDAQ:HOLX – Free Report) from a buy rating to a hold rating in a research report sent to investors on Monday morning. Several other research analysts also recently weighed in on the stock. Raymond James restated an “outperform” rating and set a $71.00 price target (down previously from $90.00) on […]
